Clinical trial
Cotrifazid Safety and Efficacy Against Malaria
NCT00322907 · Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland, Other · Terminated
Key facts
| NCT number | NCT00322907 |
|---|---|
| Title | Cotrifazid Safety and Efficacy Against Malaria |
| Official title | A Randomised Safety and Efficacy Trial of Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine+SP Against Resistant Malaria in Papua New Guinea |
| Lead sponsor | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland, Other |
| Collaborators | Papua New Guinea Institute of Medical Research Swiss Tropical & Public Health Institute |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Clinical Malaria |
| Intervention type | Drug |
| Interventions | Cotrifazid vs mefloquine or quinine+SP |
| Enrollment | 330 |
| Start date | Apr 1, 2000 |
| Completion | Jan 1, 2003 |
| First posted | May 8, 2006 |
| Last update posted | May 8, 2006 |
| Countries | Papua New Guinea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: